BOSTON–PM Group announced the official opening of their new, expanded Boston office, marking further growth in their presence in the USA. PM Group is an international project delivery firm serving the pharmaceutical industry with engineering, architectural, procurement, construction management and validation services. The new office is located just outside of Boston, at 1400 District Avenue in Burlington, MA.
“I am honored to welcome PM Group to Burlington. We have a vibrant pharmaceutical industry and they will find some terrific partners in our community who will make them feel right at home”, said State Representative Ken Gordon
“We are delighted to officially open our new, expanded Boston office and would like to thank Representative Gordon for taking time to be with us here today. The expansion of PM Group’s business in the USA is part of our strategy for further growth in the USA and serving USA companies internationally. The Greater Boston area is one of the biggest centres for the Life Science industry in the United States where employment grew by 6.3% in 2015. As one of the world’s leading pharma engineering companies, it is a natural decision to expand our operations here,” said Dave Murphy, CEO,PM Group.
PM Group has been established in Boston for seven years where the company has been working for major multi-national clients including AbbVie, Alexion, Avecia, Regeneron, EMD Serono and Sanofi. The strong relationships built with leading pharma clients have been strengthened in recent months by significant project wins for Sanofi-, Abbvie and Avecia.
“We are very excited to open our new office in Boston. It allows us to expand our capabilities to provide project delivery services to local pharmaceutical clients and will see us recruit new specialists to help us serve our clients in the USA. The expanded range of services from our multi-disciplinary teams includes master planning, concept design, architecture, engineering, procurement, commissioning, and validation,” said Donal O’Mahony, Operations Manager USA, PM Group.
“Service providers such as PM Group play a vital role in drug and device development and commercialization in Massachusetts, the world’s leading ecosystem for life sciences innovation and growth” said Travis McCready, President & CEO of the Massachusetts Life Sciences Center. “We are pleased to see the company expanding to this new facility in Burlington, further evidence that the life sciences sectors are creating jobs in all areas of the Commonwealth.”
“We are thrilled to celebrate with PM Group as they expand with a new Boston office,” said Robert K. Coughlin, President & CEO of MassBio. “We look forward to PM Group’s continued growth as they continue to provide services to the pharmaceutical industry.”
